IRCT20220211053992N7尚未招募Unknown
Bioequivalence study of Tamsulosin 0.4mg capsule manufactured by Rayhaneh Co. compared with innovator product
适应症
试验速览
- 阶段
- Unknown
- 状态
- 尚未招募
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 59 years（—）
- 性别
- Male
入选标准
- •General Health (in terms of Liver, Heart and Kidney)
- •Age (18-59 years old)
排除标准
- •Alcohol and drug addiction
- •History of drug allergy
研究者
相似试验
已完成
不适用
Bioequivalence study of Tamsulosin 0.4 mgIRCT20200623047902N4Sanamed pharma company18
招募中
不适用
Clinical study to compare the in vivo parameters of 2 Tamsulosin 0.4 mg ER Capsule formulationsIRCT20180620040164N28Cosar pharmaceutical Co.24
已完成
不适用
Clinical study to compare the in vivo parameters of 2 Tamsulosin 0.4 mg ER Capsule formulationsIRCT20180620040164N26Dorsa Pharmaceutical Co.24
已完成
1 期
Bioequivalence Study of Tamsulosin 0.4 mg Sustained Release Film-coated TabletsHealthyNCT06558032Dexa Medica Group28
招募中
4 期
Comparative efficacy assessment of Tamsulosin vs. Tamsulosin plus Pentoxifylline in the treatment of LUTS/BPH: A preliminary studyIRCT20210729052012N1Shiraz University of Medical Sciences60